ENTRADA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.96 USD | +3.37% |
|
+17.13% | -8.02% |
Chart calendar Entrada Therapeutics, Inc.
6017170e46128e66c.UDR5mDbj4GP55UOvWFIY2gr5vOfSY6wInsxqisyXBuw.FQUV1FCxkDeTqSCfPR4uiz2gxJ_lVu08xpMb0o7HZI5kAzz-ALWQKZ2ODg~9c0440920efa7b50d28969bb3468e31f
Upcoming events on Entrada Therapeutics, Inc.
Past events on Entrada Therapeutics, Inc.
| 13/03/2024 11:00 | Q4 2023 Earnings Release |
| 04/03/2024 14:10 | TD Cowen Health Care Conference |
| 14/02/2024 19:00 | Oppenheimer Healthcare Life Sciences Conference |
| 29/11/2023 20:50 | Evercore ISI HealthCONx Conference |
| 07/11/2023 12:00 | Q3 2023 Earnings Release |
| 16/10/2023 16:00 | William Blair Innovator Series Conference |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 07/09/2023 14:30 | Wells Fargo Healthcare Conference |
| 08/08/2023 12:00 | Q2 2023 Earnings Release |
| 14/06/2023 18:40 | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 14:30 | Annual General Meeting |
| 10/05/2023 12:00 | Q1 2023 Earnings Release |
| 04/04/2023 14:00 | Guggenheim Genomic Medicines and Rare Disease Day |
| 18/03/2023 | Muscular Dystrophy Association Clinical & Scientific Conference |
| 08/03/2023 19:10 | Cowen Health Care Conference |
| 06/03/2023 12:00 | Q4 2022 Earnings Release |
| 29/11/2022 20:55 | Evercore ISI HealthCONx Conference - Fireside Chat |
| 07/11/2022 12:00 | Q3 2022 Earnings Release |
| 07/09/2022 12:00 | H.C. Wainwright Global Investment Conference |
| 11/08/2022 12:00 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 129 111 16.36% | 61,9 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -50,0 -61,9 19.25% | -95,4 -96,3 0.96% | -0,32 -21,1 98.48% | -126 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -51,1 -59,1 13.52% | -97,2 -96,9 -0.37% | -3,16 -15,1 79.05% | -79,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -51,2 -55,2 7.32% | -94,6 -95,6 1.03% | 12,1 -0,83 1554.28% | -79,9 |
|
Net income Million USD | Released Forecast Spread | -26,5 | -51,2 -55,2 7.32% | -94,6 -95,6 1.03% | -6,69 -1,32 -405.39% | -81,9 |
|
EPS USD | Released Forecast Spread | -3,32 | -8,16 -6,25 -30.56% | -3,02 -3,07 1.47% | -0,20 -0,04 -370.59% | -2,29 |
| Announcement Date | 06/08/21 | 15/03/22 | 06/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 25,3 79,3 -68.16% | 18,2 9,78 85.86% | 43,7 9,60 355.69% | 41,8 23,7 76.61% | 15,2 | 16,4 | 15,2 | 16,4 | |
|
EBIT Million USD | Released Forecast Spread | -18,5 -26,4 30.16% | -22,2 -20,4 -8.67% | -23,6 -22,9 -3.05% | -25,9 -24,0 -7.86% | -25,6 -26,1 2.01% | -5,78 51,8 -111.16% | -16,3 -22,9 28.71% | 14,0 -26,1 153.73% | 4,91 -7,56 164.87% | -16,6 | -17,2 | -21,1 | -18,5 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,4 -22,5 18.01% | -21,7 -20,5 -5.71% | -23,2 -22,5 -3.02% | -25,1 -23,5 -6.97% | -24,6 -25,7 4.17% | -3,12 85,3 -103.66% | -12,1 -19,2 36.97% | 18,1 -23,2 177.87% | 9,20 -3,70 348.69% | -17,2 | -17,2 | -20,8 | -19,4 | |
|
Net income Million USD | Released Forecast Spread | -18,4 -22,5 18.01% | -21,7 -20,5 -5.71% | -23,2 -22,5 -3.02% | -25,1 -23,5 -6.97% | -24,6 -25,7 4.17% | -6,67 85,3 -107.83% | -25,9 -19,8 -30.79% | 35,5 -23,9 248.65% | -9,54 -4,19 -127.67% | -17,2 | -17,2 | -20,8 | -19,4 | |
|
EPS USD | Released Forecast Spread | -0,89 -0,72 -23.61% | -0,69 -0,66 -4.55% | -0,74 -0,72 -2.78% | -0,80 -0,75 -6.67% | -0,78 -0,83 6.02% | -0,21 2,57 -108.19% | -0,78 -0,60 -29.28% | 1,02 -0,71 242.99% | -0,28 -0,12 -128.57% | -0,56 | -0,53 | -0,62 | -0,59 | -0,69 |
| Announcement Date | 15/03/22 | 12/05/22 | 11/08/22 | 07/11/22 | 06/03/23 | 10/05/23 | 08/08/23 | 07/11/23 | 13/03/24 | - | - | - | - | - |
| Today 21:01 | HALOZYME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | RAPT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | 89BIO, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | DYNAVAX TECHNOLOGIES CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 | BEIGENE, LTD.: Q1 2024 Earnings Release |
| 08/05/2024 21:00 | MANNKIND CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 21:00 | CYTOKINETICS, INCORPORATED: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | PROTHENA CORPORATION PLC: Q1 2024 Earnings Release |
Past sector events for Entrada Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRDA Stock
- Calendar Entrada Therapeutics, Inc.
